Ketek Drug Maker Continues Discussion with FDA
January 10, 2007 10:02

Ketek Drug Maker Continues Discussion with FDASanofi-Aventis, the drug maker, said yesterday that it planned additional discussions with the Food and Drug Administration after an advisory panel to the agency said the company should not be allowed to continue... (Read Article)

Ketek and Clinical Trials
January 11, 2007 09:59

Ketek and Clinical Trials

Faropenem Phase III clinical trial stopped to consider exclusion of Ketek comparator Co announces that the current phase III clinical trial comparing faropenem medoxomil to placebo and Ketek in patients being treated for acute exacerbation of chronic bronchitis is being temporarily stopped to consider the exclusion of the Ketek arm in the study.